No Picture
News

Bristol-Myers is making a bee-line to the FDA with positive liso-cel data — but is it too late in the CAR-T game?

Bristol-Myers Squibb came to ASH this past weekend with a variety of messages on the new cancer drugs they had acquired in the big Celgene buyout, including liso-cel, the lead CAR-T program picked up in the $9 billion Juno acquisition. And one of the m… […]

No Picture
News

Unlearn.AI Announces Results Generated from First-of-its-Kind Machine Learning Platform to Accelerate Alzheimer’s Drug Development

SAN FRANCISCO–(BUSINESS WIRE)–Unlearn.AI announces results generated from first-of-its-kind machine learning platform to accelerate Alzheimer’s drug development. […]

No Picture
News

Unlearn.AI Announces Results Generated from First-of-its-Kind Machine Learning Platform to Accelerate Alzheimer’s Drug Development

SAN FRANCISCO–(BUSINESS WIRE)–Unlearn.AI announces results generated from first-of-its-kind machine learning platform to accelerate Alzheimer’s drug development. […]